APA (7th ed.) Citation

BJH, L., KY, F., T, L., J, O., S, T., TW, C., . . . YG, T. (2025). BCG response and oncological outcomes in high risk nonmuscle invasive bladder cancer following previously treated upper tract urothelial carcinoma: A propensity-matched analysis. Urologic oncology, 43(7), 440.e1-440.e9. https://doi.org/10.1016/j.urolonc.2025.03.026

Chicago Style (17th ed.) Citation

BJH, Lim, et al. "BCG Response and Oncological Outcomes in High Risk Nonmuscle Invasive Bladder Cancer Following Previously Treated Upper Tract Urothelial Carcinoma: A Propensity-matched Analysis." Urologic Oncology 43, no. 7 (2025): 440.e1-440.e9. https://doi.org/10.1016/j.urolonc.2025.03.026.

MLA (9th ed.) Citation

BJH, Lim, et al. "BCG Response and Oncological Outcomes in High Risk Nonmuscle Invasive Bladder Cancer Following Previously Treated Upper Tract Urothelial Carcinoma: A Propensity-matched Analysis." Urologic Oncology, vol. 43, no. 7, 2025, pp. 440.e1-440.e9, https://doi.org/10.1016/j.urolonc.2025.03.026.